Evidence map›Paper›PMID 14982741›Full record

ArticleJournal of neurovirology2004

CD8+ cell depletion amplifies the acute retroviral syndrome.

Lisa J Madden, Michelle A Zandonatti, Claudia T Flynn, Mike A Taffe, M Cecilia G Marcondes, Jörn E Schmitz, Keith A Reimann, Steven J Henriksen, Howard S Fox

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neurovirology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Drug induced increases in CNS dopamine alter monocyte, macrophage and T cell functions: implications for HAND.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2013
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Strategies to modulate immune responses: a new frontier for gene therapy.Molecular therapy : the journal of the American Society of Gene Therapy · 2009
    Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Lisa J MaddenDepartment of Neuropharmacology, The Scripps Research Institute, La Jolla, California 92037, USA. madden@scripps.edu
Michelle A Zandonatti
Claudia T Flynn
Mike A Taffe
M Cecilia G Marcondes
Jörn E Schmitz
Keith A Reimann
Steven J Henriksen
Howard S Fox
Scripps Research Institute · USBeth Israel Deaconess Medical Center · USHarvard University · US

Funding

Therapeutics Core (Page 286)P30MH062261 · NIMH · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI GENDELMAN, HOWARD E · 2000 to 2021
$37.7M
Project 4P01DA012444 · NIDA · SCRIPPS RESEARCH INSTITUTE · PI HENRIKSEN, STEVEN · 2000 to 2004
$8.9M
RESOURCE FOR NONHUMAN PRIMATE CELL DEPLETING ANTIBODIESR24RR016001 · NCRR · BETH ISRAEL DEACONESS MEDICAL CENTER · PI REIMANN, KEITH A. · 2000 to 2011
$8.1M
PERIPHERAL VIRAL LOAD AND SIV-INDUCED CNS DYSFUNCTIONR01MH059468 · NIMH · SCRIPPS RESEARCH INSTITUTE · PI FOX, HOWARD S. · 1999 to 2003
$2.1M
SIV Behavioral Pathology: Manipulation of Viral LoadR01MH061692 · NIMH · SCRIPPS RESEARCH INSTITUTE · PI TAFFE, MICHAEL A · 2001 to 2004
$1.6M
NEUROIMMUNE FACTORS IN SIV INDUCED CNS DYSFUNCTIONR01MH061224 · NIMH · SCRIPPS RESEARCH INSTITUTE · PI FOX, HOWARD S. · 1999 to 2003
$1.3M
NCRR NIH HHS R24 RR016001NCRR NIH HHS RR16001NIDA NIH HHS DA12444NIDA NIH HHS P01 DA012444NIMH NIH HHS MH595468NIMH NIH HHS MH61224NIMH NIH HHS MH61692NIMH NIH HHS MH62261NIMH NIH HHS R01 MH059468NIMH NIH HHS R01 MH061692
6 · The paper itself

Abstract

The duration and severity of the symptomatology present during the early phase of human immunodeficiency virus (HIV) infection (known as the acute retroviral syndrome) is associated with alterations in the clinical profile of infection, such as a shortening of duration between infection with HIV and the onset of neurocognitive impairment and acquired immunodeficiency syndrome (AIDS). Viral-specific CD8+ cytotoxic T lymphocytes (CTLs) and CD8+ natural killer (NK) cells play a key role in antiviral immunity. Loss of CD8+ cells or their functional impairment during the early period of infection is associated with a rapid progression to AIDS in nonhuman primate studies. However, no studies have determined whether CD8+ cell loss or impairment is associated with symptoms of acute retroviral illness such as fever. In this study, the authors compared the early phase of simian immunodeficiency virus (SIV) infection in animals that were treated with the anti-CD8 monoclonal antibody cM-T807 to deplete CD8+ cells during the early period of infection (SIV+ CD8- group) to those with intact CD8+ cells (SIV+ CD8+ group). The SIV+ CD8- group had an enhanced acute retroviral syndrome when compared to the SIV+ CD8+ group. The SIV+ CD8- group also had prolonged high viral loads and distinct alterations in the proinflammatory cytokines interleukin (IL)-6 and interferon (IFN)-alpha, as well as in monocyte chemoattractant protein (MCP)-1. CD8+ cell depletion, therefore, appears to enhance symptoms of the acute retroviral syndrome and alters several of the immunological factors associated with the early phase of infection.

Indexed as

Acute DiseaseAnimalsCD8-Positive T-LymphocytesChemokine CCL2FeverInterferon-alphaInterleukin-6Macaca mulattaMaleMotor ActivitySimian Acquired Immunodeficiency SyndromeSurvival AnalysisViral LoadChemokine CCL2Interferon-alphaInterleukin-6

Identifiers

PMID14982741
OpenAlexW1966584444

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.